Concepedia
Statistics
Publications
6
Citations
892
H-Index
Active since
2001
Affiliations
Hôpital René Huguenin(Current)
Institut Gustave Roussy
Hôpital Paul-Brousse
M. Riofrio is an author at Hôpital René Huguenin specializing in cancer pharmacology, oncology, and pharmacology.
Publications per year
2001–2006
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
Alejandro Yovine, M. Riofrio, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2004 · 310 citations
Medicine, Oncology, Pharmacokinetics +13
Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity
Suzette Delaloge, Alejandro Yovine, A. Taamma et al. · Journal of Clinical Oncology · 2001 · 167 citations
Medicine, Oncology, Pharmacology +15
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
A. Taamma, J. L. Misset, M. Riofrio et al. · Journal of Clinical Oncology · 2001 · 160 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma
Laurent Zelek, S. Barthier, M. Riofrio et al. · Cancer · 2001 · 157 citations · Full text
Medicine, Oncology, Pharmacology +17
A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
Laurent Zelek, Alejandro Yovine, Étienne Brain et al. · British Journal of Cancer · 2006 · 86 citations · Full text
1–5 of 6